Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

COMy 2020

Therapy Updates

View all
5:33
The importance of tailored treatment approach in multiple myeloma
Paul Richardson • 18 Oct 2020
3:24
The impact of CHIP expression on multiple myeloma treatment
Irene Ghobrial • 1 Oct 2020
1:30
Treatment approaches for fit and frail multiple myeloma patients
Jesús San Miguel • 8 Oct 2020
5:11
New developments in maintenance therapy for multiple myeloma
Graham Jackson • 2 Oct 2020

Immuno-Oncology

View all
4:52
CD38: a promising target for multiple myeloma antibody therapy
Saad Usmani • 5 Oct 2020
5:15
Promising clinical trials for multiple myeloma: KarMMa, CARTITUDE and EVOLVE
Noopur Raje • 21 Sep 2020

MRD Updates

View all
2:51
Profiling deep minimal residual disease in multiple myeloma
Bruno Paiva • 23 Sep 2020
1:46
The assets of MRD in myeloma
Bruno Paiva • 23 Sep 2020
The content of VJHemOnc is intended for healthcare professionals